Regarding IC receptor expression (Figure 1C), the ND-AML patients had significantly more TIGIT+CD3+, TIGIT+CD4+, and TIGIT+CD8+ T cells compared to the HCs. This evidence concerns the gene CD4 and acute myeloid leukemia.